Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

C4 THERAPEUTICS, INC.

(CCCC)
Prezzo in differita. Tempo differito Nasdaq - 17/09 22:00:00
49.95 USD   +0.91%
24/06C4 THERAPEUTICS, INC.: Brookline Capital Management rimane Buy
MM
04/06C4 THERAPEUTICS, INC.: da HC Wainwright è Buy
MM
31/03C4 THERAPEUTICS, INC.: giudizio positivo da BMO Capital
MM
RiassuntoQuotazioniGraficiNotizieRatingAgendaSocietąFinanzaConsensusRevisioniDerivati 
 RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Tutte le notizie su C4 THERAPEUTICS, INC.
24/06C4 THERAPEUTICS, INC.: Brookline Capital Management rimane Buy
MM
04/06C4 THERAPEUTICS, INC.: da HC Wainwright è Buy
MM
31/03C4 THERAPEUTICS, INC.: giudizio positivo da BMO Capital
MM
Tutte le notizie
Notizie in altre lingue su C4 THERAPEUTICS, INC.
17/09INSIDER SELL: C4 Therapeutics
15/09Certain Common Stock of C4 Therapeutics, Inc. are subject to a Lock-Up Agreem..
15/09Certain Stock Options of C4 Therapeutics, Inc. are subject to a Lock-Up Agree..
14/09INSIDER SELL: C4 Therapeutics
12/08C4 THERAPEUTICS': Q2 Loss Narrows, Revenue Grows; Secures Orphan Drug Designati..
11/08C4 THERAPEUTICS: Management's Discussion and Analysis of Financial Condition an..
11/08C4 THERAPEUTICS: Dosed First Patient in Phase 1/2 Clinical Trial of CFT7455, a ..
11/08C4 THERAPEUTICS, INC.: Results of Operations and Financial Condition, Regulatio..
11/08C4 THERAPEUTICS: Reports Recent Business Highlights and Second Quarter 2021 Fin..
11/08C4 Therapeutics Announces FDA Orphan Drug Designation for CFT7455 for the Tre..
Pił notizie
Raccomandazione degli analisti su C4 THERAPEUTICS, INC.
24/06C4 THERAPEUTICS, INC.: Brookline Capital Management rimane Buy
MM
04/06C4 THERAPEUTICS, INC.: da HC Wainwright è Buy
MM
31/03C4 THERAPEUTICS, INC.: giudizio positivo da BMO Capital
MM
Pił raccomandazioni